Pancuronium and Haloperidol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pancuronium (pancuronium bromide) and Haloperidol (haloperidol). Common drug interactions include fatigue among females and renal impairment among males.

The phase IV clinical study analyzes what interactions people have when they take Pancuronium and Haloperidol. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Pancuronium?

Pancuronium has active ingredients of pancuronium bromide. eHealthMe is studying from 1,328 Pancuronium users. Check the latest studies of Pancuronium.

What is Haloperidol?

Haloperidol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 16,637 Haloperidol users. Check the latest studies of Haloperidol.

On Jul, 08, 2026

14 people who take Pancuronium and Haloperidol together, and have interactions are studied.

Pancuronium and Haloperidol drug interactions.

What are the common drug interactions of Pancuronium and Haloperidol, by gender? *:

female:

Fatigue (feeling of tiredness)
Flat affect (absence of emotional response to a situation)
Fungal infection
Gamma-glutamyltransferase increased
Gastric hypomotility (less movement of stomach)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hallucination, visual (seeing things that aren't there)
Head injury
Headache postoperative
Hemiplegia (paralysis of one side of the body)

male:

Renal impairment (severely reduced kidney function)
Anxiety
Coma (state of unconsciousness lasting more than six hours)
Dysphasia (language disorder marked by deficiency in the generation of speech)
Quadriplegia (a four limb paralysis)
Abasia (inability to walk)
Agitation (state of anxiety or nervous excitement)
Anticholinergic syndrome (absolute or relative reduction in cholinergic activity in the central nervous system)
Aortic valve disease
Blood creatinine increased

What are the common drug interactions of Pancuronium and Haloperidol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Abasia (inability to walk)
Aortic valve disease
Cardiac failure congestive
Cardiac valve disease (heart valve disease)
Cerebral artery embolism (sudden blocking of an artery by a clot or foreign material)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Coma (state of unconsciousness lasting more than six hours)
Dysstasia (difficulty in standing)
Kidney transplant rejection
Leukaemoid reaction (elevated white blood cell count, or leukocytosis, that is a physiological response to stress or infection)

40-49:

Intracranial aneurysm (bulging, weak area in the wall of a cranial artery)
Joint dislocation (a joint position is changed from normal position)
Laceration (tearing of soft body tissue)
Pain
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Prothrombin level increased
Pyrexia (fever)
Respiratory failure (inadequate gas exchange by the respiratory system)
Respiratory failure (excl neonatal) (inadequate gas exchange by the respiratory system(excluding neonatal))

50-59:

Agitation (state of anxiety or nervous excitement)
Anticholinergic syndrome (absolute or relative reduction in cholinergic activity in the central nervous system)
Coma (state of unconsciousness lasting more than six hours)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hypersensitivity
Multi-organ failure (multisystem organ failure)
Oliguria (not enough urine)

60+:

Anxiety
Death
Dysphasia (language disorder marked by deficiency in the generation of speech)
Quadriplegia (a four limb paralysis)
Blood creatinine increased
Blood urea increased
Brain stem infarction (brainstem stroke)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Haematocrit decreased
Po2 decreased

What are the existing conditions these people have? *

Dyslipidaemia (abnormal amount of lipids): 2 people, 14.29%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 14.29%
Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 2 people, 14.29%
Pneumonia: 2 people, 14.29%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 14.29%
Stress And Anxiety: 2 people, 14.29%
Fatigue (feeling of tiredness): 2 people, 14.29%
Enlarged Prostate: 2 people, 14.29%
Weight Decreased: 1 person, 7.14%
Acne (skin problems that cause pimples): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Pancuronium and Haloperidol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously